Skip to content

Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The James

Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at Ohio State University/The James.

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01643954
Enrollment
1531
Registered
2012-07-18
Start date
2008-09-23
Completion date
2027-07-31
Last updated
2025-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

prostatectomy, surgery, prostate cancer

Brief summary

This is a retrospective/prospective Analysis of surgical outcomes of robotic prostatectomy.

Detailed description

This retrospective / prospective study will allow us to collect and analyze the presurgical, peri-operative, and outcome data of patients who undergo robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center, beginning February 2008 onwards.

Interventions

robotic assisted surgery

Sponsors

Ohio State University Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

ARM A: Inclusion Criteria: * Patients with prostate cancer who have undergone robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center. * Ability to understand and willingness to sign the written informed consent document. * 18 years and older ARM B: Inclusion Criteria: * Patients with prostate cancer that will undergo robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center. * Ability to understand and willingness to sign the written informed consent document. * 18 years and older

Design outcomes

Primary

MeasureTime frame
Collect and analyze descriptive characteristics of patient population and summarize patient outcome data.up to 20 years

Secondary

MeasureTime frame
Correlate the patient characteristics to the surgical outcomes.up to 20 years
Determine the overall survivalup to 20 years
Determine the rate of local recurrence in patients undergoing robotic prostatectomy and compare these metrics to historical controls.up to 20 years
disease- free survivalup to 20 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026